123 related articles for article (PubMed ID: 3765123)
1. Significance of histologic grading in the prognosis of ovarian tumors.
Gáti E; Sugár J; Szentirmay Z; Töttössy B
Tumori; 1986 Aug; 72(4):427-30. PubMed ID: 3765123
[TBL] [Abstract][Full Text] [Related]
2. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.
Shimizu Y; Kamoi S; Amada S; Hasumi K; Akiyama F; Silverberg SG
Gynecol Oncol; 1998 Jul; 70(1):2-12. PubMed ID: 9698465
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of histologic grading of ovarian carcinomas.
Sato Y; Shimamoto T; Amada S; Asada Y; Hayashi T
Int J Gynecol Pathol; 2003 Jan; 22(1):52-6. PubMed ID: 12496698
[TBL] [Abstract][Full Text] [Related]
4. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
5. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
6. Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Shimazaki H; Takano M; Yoshikawa T; Kuzuya K; Tsuda H; Kurachi H; Kigawa J; Kikuchi Y; Sugiyama T; Matsubara O
Int J Gynecol Pathol; 2011 Sep; 30(5):431-41. PubMed ID: 21804390
[TBL] [Abstract][Full Text] [Related]
7. Histological grading of ovarian clear cell adenocarcinoma: proposal for a simple and reproducible grouping system based on tumor growth architecture.
Yamamoto S; Tsuda H; Shimazaki H; Takano M; Yoshikawa T; Kuzuya K; Tsuda H; Kurachi H; Kigawa J; Kikuchi Y; Sugiyama T; Matsubara O
Int J Gynecol Pathol; 2012 Mar; 31(2):116-24. PubMed ID: 22317866
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary.
Malkasian GD; Melton LJ; O'Brien PC; Greene MH
Am J Obstet Gynecol; 1984 Jun; 149(3):274-84. PubMed ID: 6328995
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract][Full Text] [Related]
11. Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.
Sadlecki P; Walentowicz P; Bodnar M; Marszalek A; Grabiec M; Walentowicz-Sadlecka M
Tumour Biol; 2017 May; 39(5):1010428317706230. PubMed ID: 28488545
[TBL] [Abstract][Full Text] [Related]
12. [Histologic type and tumor maturity as prognostic factors in malignant epithelial tumors of the ovary].
Jukić S; Ilić J; Krstulović B; Krznar B; Culig V
Jugosl Ginekol Perinatol; 1989; 29(3-4):137-9. PubMed ID: 2601368
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.
Diefenbach CS; Soslow RA; Iasonos A; Linkov I; Hedvat C; Bonham L; Singer J; Barakat RR; Aghajanian C; Dupont J
Cancer; 2006 Oct; 107(7):1511-9. PubMed ID: 16944535
[TBL] [Abstract][Full Text] [Related]
14. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
15. A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006.
Hannibal CG; Vang R; Junge J; Kjaerbye-Thygesen A; Kurman RJ; Kjaer SK
Gynecol Oncol; 2012 Jun; 125(3):655-60. PubMed ID: 22370600
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in ovarian cancer.
Rakar S; Kovacic J; Cavic M; Lukanovic A; Mozina A
Eur J Gynaecol Oncol; 1990; 11(3):171-3. PubMed ID: 2170137
[TBL] [Abstract][Full Text] [Related]
17. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
[TBL] [Abstract][Full Text] [Related]
18. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
19. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.
Levesque MA; Katsaros D; Yu H; Zola P; Sismondi P; Giardina G; Diamandis EP
Cancer; 1995 Mar; 75(6):1327-38. PubMed ID: 7882283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
